These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11498419)

  • 1. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques.
    Sugahara T; Korogi Y; Kochi M; Ushio Y; Takahashi M
    AJNR Am J Neuroradiol; 2001 Aug; 22(7):1306-15. PubMed ID: 11498419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
    Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
    AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
    Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
    AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
    Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
    Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.
    Cha S; Yang L; Johnson G; Lai A; Chen MH; Tihan T; Wendland M; Dillon WP
    AJNR Am J Neuroradiol; 2006 Feb; 27(2):409-17. PubMed ID: 16484420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
    Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
    Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.
    Rollin N; Guyotat J; Streichenberger N; Honnorat J; Tran Minh VA; Cotton F
    Neuroradiology; 2006 Mar; 48(3):150-9. PubMed ID: 16470375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
    Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
    J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients.
    Donahue KM; Krouwer HG; Rand SD; Pathak AP; Marszalkowski CS; Censky SC; Prost RW
    Magn Reson Med; 2000 Jun; 43(6):845-53. PubMed ID: 10861879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.